|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 01/09 | Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target | MT |
| 07/08 | Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib | DJ |
| Market Cap | 81Cr 70Cr 66Cr 60Cr 111.98Cr 7.75TCr 112.99Cr 783.09Cr 301.39Cr 3.93TCr 304.3Cr 297.64Cr 12TCr | P/E 2026 * |
-8.52x | P/E 2027 * | -7x |
|---|---|---|---|---|---|
| Enterprise Value | 66Cr 57Cr 53Cr 49Cr 91Cr 6.28TCr 92Cr 635.14Cr 244.44Cr 3.19TCr 246.8Cr 241.41Cr 10TCr | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 124x |
| Free-Float |
97.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : ACLS THER
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 17/01/2024 |
Hugh Davis
PSD | President | 67 | 18/11/2024 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 01/01/2023 |
Anand Mehra
BRD | Director/Board Member | 50 | 01/09/2014 |
| Director/Board Member | 59 | 01/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25% | -0.96% | +45.25% | +102.76% | 6.85TCr | |
| -1.09% | -4.97% | +31.10% | +76.56% | 6.29TCr | |
| -1.18% | +0.51% | -13.53% | +384.69% | 2.81TCr | |
| -2.74% | -3.53% | +26.13% | +13.50% | 2.56TCr | |
| -1.76% | -7.14% | -5.57% | -19.75% | 2.47TCr | |
| -2.39% | -4.23% | +18.42% | -20.95% | 1.98TCr | |
| -1.86% | +1.15% | +205.44% | +353.89% | 1.77TCr | |
| -1.37% | -3.77% | -9.38% | +528.34% | 1.47TCr | |
| -1.54% | -1.88% | +50.03% | +159.75% | 1.45TCr | |
| Average | -1.58% | -1.33% | +38.65% | +175.42% | 3.07TCr | |
| Weighted average by Cap. | -1.28% | -1.41% | +35.43% | +139.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.38L 54.51L 51.43L 46.85L 87.59L 61Cr 88.38L 6.13Cr 2.36Cr 31Cr 2.38Cr 2.33Cr 98Cr | 53.38L 45.91L 43.31L 39.46L 73.76L 51Cr 74.43L 5.16Cr 1.99Cr 26Cr 2Cr 1.96Cr 82Cr |
| Net income | -9.03Cr -7.77Cr -7.33Cr -6.68Cr -12Cr -863.62Cr -13Cr -87Cr -34Cr -438.04Cr -34Cr -33Cr -1.39TCr | -11Cr -9.66Cr -9.12Cr -8.3Cr -16Cr -1.07TCr -16Cr -108.56Cr -42Cr -544.77Cr -42Cr -41Cr -1.73TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.46TCr -21Cr -147.95Cr -57Cr -742.44Cr -57Cr -56Cr -2.36TCr | -15Cr -13Cr -12Cr -11Cr -20Cr -1.4TCr -20Cr -141.62Cr -55Cr -710.68Cr -55Cr -54Cr -2.26TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
